NCT02702856View on ClinicalTrials.gov

Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Prostate Cancer
Interventions
OTHER

ExoIntelliScore Prostate

Sponsors
All Listed Sponsors
lead

Exosome Diagnostics, Inc.

INDUSTRY

NCT02702856 - Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer | Biotech Hunter | Biotech Hunter